Homepage
Policies & Regulations
Biosimilar update....
April 1, 2025
Pharmacy

​​​Independence Blue Cross (IBX) is committed to finding innovative ways to make specialty drugs more affordable while ensuring members have access to the medications they need. That's why IBX is closely monitoring the launch of biosimilars for two key drugs, Stelara® (ustekinumab) and Actemra® (tocilizumab). Effective July 1, 2025, IBX will be implementing the following updates to both its medical and prescription drug programs

Claims & Billing
Updates to the EPP
March 21, 2025
Reimbursement
​​View your Explanation of Provider Payment (EPP) for recently processed claims directly through the EOB & Remittance transaction in the Practice Management application of the Provider Engagement, Analytics & Reporting (PEAR) portal.
Programs
Celebrating National Doctors’ Day
March 31, 2025
Provider Programs
​We at Independence Blue Cross would like to thank you, our community of doctors, for all you do to improve the health and well-being of the people we serve, and you care for. You dedicate your lives to helping others and that is something we truly value. Working hand-in-hand with you to provide the tools, data, and support you need to deliver the most effective care to your patients (our members) is something we're proud of.

Provider Services:

  • Independence: 1-800-ASK-BLUE (1-800-275-2583)
  • Independence Administrators: 1-888-356-7899​​​

PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​




Filter to find the news that is relevant to your role.

Provider Services:

  • Independence: 1-800-ASK-BLUE (1-800-275-2583)
  • Independence Administrators: 1-888-356-7899​​​

PEAR​ portal support:1-833-444-PEAR (1-833-444-7327)

Provider Network Services (PNS) contacts:

Other contact information​​




       
            Loading...